{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:26:14Z","timestamp":1787775974411,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral ischemia-reperfusion (IR) injury is a significant contributor to stroke-related morbidity, driven by mitochondrial dysfunction, oxidative stress, and inflammation. This study investigates the neuroprotective effects of sonlicromanol (Son), a mitochondria-targeted compound, in a rat model of cerebral IR injury, focusing on the role of sirtuin 3 (SIRT3)-mediated mitochondrial and inflammasome regulation. Male Sprague\u2013Dawley rats underwent transient middle cerebral artery occlusion and were assigned to five groups: control, IR, IR + Son, IR + 3-TYP (SIRT3 inhibitor), and IR + 3-TYP + Son. Son was administered intraperitoneally at reperfusion onset, with or without 3-TYP. IR significantly impaired 24 h postreperfusion neuromotor performance, increased infarct size, and disrupted mitochondrial function (membrane potential, Adenosine Triphosphate [ATP]), elevating reactive oxygen species and inflammasome activation (NOD-like receptor family pyrin domain containing 3; interleukin-1 beta, caspase-1, gasdermin-D). Treatment with Son significantly improved neuromotor performance, reduced infarct size, restored mitochondrial function, increased antioxidant defenses (glutathione, manganese superoxide dismutase or MnSOD, peroxiredoxin 3), and attenuated inflammasome-mediated pyroptosis. These effects correlated with upregulated SIRT3, forkhead box O3, and uncoupling protein 2 expression evaluated by Western blot. SIRT3 inhibition with 3-TYP partially reversed Son\u2019s benefits, underscoring SIRT3\u2019s pivotal role. However, some protective effects persisted despite SIRT3 inhibition, suggesting additional mechanisms. These findings highlight Son\u2019s therapeutic potential in mitigating cerebral IR injury through SIRT3-dependent mitochondrial protection and inflammasome suppression, offering insights for stroke treatment development.<\/jats:p>","DOI":"10.4103\/ejpi.ejpi-d-25-00022","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T05:00:16Z","timestamp":1754456416000},"page":"256-265","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["SIRT3-mediated Mitochondrial Regulation Underlies Sonlicromanol\u2019s Protection against Cerebral Ischemia-reperfusion Injury in Rats"],"prefix":"10.4103","volume":"68","author":[{"given":"Hanfu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, Traditional Chinese Medicine Hospital of Baoji, Baoji, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugwah-Oguejiofor Chinenye","family":"Jane","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ankang People\u2019s Hospital, Ankang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"R1-20251006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","article-title":"Ischemia-reperfusion injury: Molecular mechanisms and therapeutic targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R2-20251006","doi-asserted-by":"crossref","first-page":"1500647","DOI":"10.3389\/fnins.2024.1500647","article-title":"The mitochondria as a potential therapeutic target in cerebral I\/R injury","volume":"18","author":"Fang","year":"2024","journal-title":"Front Neurosci"},{"key":"R3-20251006","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","article-title":"An update on the regulatory mechanisms of NLRP3 inflammasome activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R4-20251006","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/hmg\/ddx100","article-title":"Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress","volume":"26","author":"Shi","year":"2017","journal-title":"Hum Mol Genet"},{"key":"R5-20251006","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","article-title":"The sirtuin family in health and disease","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R6-20251006","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.freeradbiomed.2013.05.002","article-title":"SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage","volume":"63","author":"Tseng","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"R7-20251006","doi-asserted-by":"crossref","first-page":"e023065","DOI":"10.1161\/JAHA.121.023065","article-title":"Sirtuin 3 and uncouplin protein 2, the missing link between genetics, metabolism, and pulmonary arterial hypertension","volume":"10","author":"Lajoie","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R8-20251006","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/brain\/awae277","article-title":"Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation","volume":"148","author":"Smeitink","year":"2025","journal-title":"Brain"},{"key":"R9-20251006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4149\/gpb_2023003","article-title":"Targeting AMPK\/eNOS pathway and mitochondria by sonlicromanol protects myocardial cells against ischemia-reperfusion injury","volume":"42","author":"Liao","year":"2023","journal-title":"Gen Physiol Biophys"},{"key":"R10-20251006","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1038\/s41598-018-24900-3","article-title":"KH176 safeguards mitochondrial diseased cells from redox stress-induced cell death by interacting with the thioredoxin system\/peroxiredoxin enzyme machinery","volume":"8","author":"Beyrath","year":"2018","journal-title":"Sci Rep"},{"key":"R11-20251006","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.stemcr.2021.07.002","article-title":"Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m. 3243A>G heteroplasmy in iPSC-derived neurons","volume":"16","author":"Klein Gunnewiek","year":"2021","journal-title":"Stem Cell Reports"},{"key":"R12-20251006","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10557-021-07189-9","article-title":"The redox modulating sonlicromanol active metabolite KH176m and the antioxidant MPG protect against short-duration cardiac ischemia-reperfusion injury","volume":"35","author":"Xiao","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"R13-20251006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2024.02.017","article-title":"New perspectives in neuroprotection for ischemic stroke","volume":"550","author":"P\u00e9rez-Mato","year":"2024","journal-title":"Neuroscience"},{"key":"R14-20251006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: Mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R15-20251006","doi-asserted-by":"crossref","first-page":"101883","DOI":"10.1016\/j.mito.2024.101883","article-title":"Mitochondrial mechanisms in cerebral ischemia \u2013Reperfusion Injury: Unravelling the intricacies","volume":"77","author":"Kumar Saini","year":"2024","journal-title":"Mitochondrion"},{"key":"R16-20251006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: Mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R17-20251006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.trsl.2022.08.006","article-title":"NLRP3 inflammasome in neurodegenerative disease","volume":"252","author":"Anderson","year":"2023","journal-title":"Transl Res"},{"key":"R18-20251006","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.7150\/thno.45922","article-title":"Mitochondrial sirtuin 3: New emerging biological function and therapeutic target","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"R19-20251006","doi-asserted-by":"crossref","first-page":"117084","DOI":"10.1016\/j.biopha.2024.117084","article-title":"New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases","volume":"178","author":"Chen","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R20-20251006","doi-asserted-by":"crossref","first-page":"109918","DOI":"10.1016\/j.abb.2024.109918","article-title":"UCP2 overexpression activates SIRT3 to regulate oxidative stress and mitochondrial dynamics induced by myocardial injury","volume":"753","author":"Geng","year":"2024","journal-title":"Arch Biochem Biophys"},{"key":"R21-20251006","doi-asserted-by":"crossref","first-page":"19062","DOI":"10.1074\/jbc.M500566200","article-title":"Persistent nuclear factor-kappa B activation in Ucp2-\/- mice leads to enhanced nitric oxide and inflammatory cytokine production","volume":"280","author":"Bai","year":"2005","journal-title":"J Biol Chem"}],"container-title":["Journal of Physiological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ejpi.EJPI-D-25-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:47:34Z","timestamp":1787773654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ejpi.EJPI-D-25-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ejpi.ejpi-d-25-00022","relation":{},"ISSN":["2950-6344","2950-6352"],"issn-type":[{"value":"2950-6344","type":"print"},{"value":"2950-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"2025-04-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}